Detalles de la búsqueda
1.
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
BMC Cancer
; 18(1): 903, 2018 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30231854
2.
Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer.
Cancers (Basel)
; 15(7)2023 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046697
3.
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.
Cancers (Basel)
; 15(14)2023 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37509290
4.
Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor.
Cancers (Basel)
; 14(11)2022 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681611
5.
Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine.
Oncotarget
; 12(7): 626-637, 2021 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33868584
6.
Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential.
Oncotarget
; 10(38): 3681-3693, 2019 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217902
7.
A usable model of "decathlon winner" cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence.
Oncotarget
; 9(13): 11071-11082, 2018 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29541397
8.
Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential.
Oncotarget
; 13: 1272, 2022 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36395366
Resultados
1 -
8
de 8
1
Próxima >
>>